Clinical Trials Browser

Advanced Non Small Cell Lung Cancer × durvalumab × 90 days × Clear all

NCT02143466 2026-01-30

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

Phase 1 Active not recruiting

Advanced Non Small Cell Lung Cancer